PRKN and Parkinson disease: The identification of a specific set of sites targeted by endogenous Parkin in cell types relevant to Parkinson’s will provide impetus to the development of facile proteomic and cell-based assays to monitor Parkin activity that will aid drug discovery and translational efforts to activate PINK1 and Parkin as a potential therapeutic strategy in PD (61).